Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Ebola virus

This page shows the latest Ebola virus news and features for those working in and with pharma, biotech and healthcare.

WHO launches R&D efforts to identify pathogens that could cause future pandemics

WHO launches R&D efforts to identify pathogens that could cause future pandemics

Over 300 scientists will convene to discuss over 25 virus and bacteria, including ‘Disease X’. ... The list, which is not exhaustive, currently includes COVID-19, Crimean-Cong haemorrhagic fever, Ebola virus disease and Marburg virus disease, Lassa

Latest news

  • Merck to donate Sudan Ebola virus vaccine to International AIDS Vaccine Initiative Merck to donate Sudan Ebola virus vaccine to International AIDS Vaccine Initiative

    Merck &Co – known as MSD outside the US and Canada – has announced that, in response to the Sudan Ebola virus outbreak in Uganda, it is planning to produce and donate doses ... of its investigational Sudan Ebola virus vaccine candidate to the

  • Roche acquires test maker TIB Molbiol Roche acquires test maker TIB Molbiol

    The two companies have collaborated for more than 20 years ‘to rapidly address critical healthcare needs including biological threats’ that include SARS, anthrax, avian influenza virus H5N1, MERS, the novel influenza ... virus H1N1 swine, Ebola virus,

  • Roche expands infectious disease test portfolio Roche expands infectious disease test portfolio

    The long-running partnership to ‘rapidly address critical healthcare needs’ has included biological threats as serious as Severe Acute Respiratory Syndrome (SARS), anthrax, avian influenza virus (H5N1), Middle East Respiratory Syndrome

  • Regeneron scores first FDA approval for Ebola antibody treatment Regeneron scores first FDA approval for Ebola antibody treatment

    The US Food and Drug Administration (FDA) has approved Regeneron’s Inmazeb, making it the first FDA-approved treatment for the Ebola virus in adults and children. ... Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) is a mixture of three

  • AbbVie, Amgen and Takeda team up for joint COVID-19 trial AbbVie, Amgen and Takeda team up for joint COVID-19 trial

    This includes Gilead’s investigational antiviral drug remdesivir, which the company had originally been evaluating as a treatment for Ebola virus disease. ... Unfortunately, not all efforts to repurpose drugs have proved successful, with AbbVie’s

More from news
Approximately 4 fully matching, plus 33 partially matching documents found.

Latest Intelligence

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    Scientists have since industrialised the concept, leading to the development of antibodies against Ebola and respiratory syncytial virus. ... The same platform underpins CanSino’s Ebola vaccine that won approval in China in 2017.

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    Prior to the coronavirus outbreak, Gilead had primarily been focused on testing remdesivir’s potential in Ebola virus disease, although the antiviral also demonstrated promise in other coronaviruses, including severe acute ... This is particularity

  • Communicating in a crisis Communicating in a crisis

    Nobody working in the healthcare world has been able to ignore the outbreak of the Ebola virus in West Africa this past year. ... Timeline of Ebola outbreak in West Africa. December 2013. Two-year-old child contracts Ebola virus in Guinea.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Cool heads in a crisis?

    First there was Ebola and now there is Zika; two official World Health Organization (WHO) Public Health Emergencies of International Concern (PHEIC) within as many years.

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...

Quick links